 | • レポートコード：TPM-B04035 • 出版社/出版日：Transparency Market Research / 2018年1月 • レポート形態：英文、PDF、180ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、女性向け医療の世界市場について調べ、女性向け医療の世界規模、市場動向、市場環境、治療方法別分析、疾患徴候別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・女性向け医療の世界市場動向 ・女性向け医療の世界市場環境 ・女性向け医療の世界市場規模 ・女性向け医療の世界市場規模：治療方法別 ・女性向け医療の世界市場規模：疾患徴候別 ・女性向け医療の世界市場：地域別市場規模・分析 ・女性向け医療の北米市場規模・予測 ・女性向け医療のアメリカ市場規模・予測 ・女性向け医療の中南米市場規模・予測 ・女性向け医療のヨーロッパ市場規模・予測 ・女性向け医療のアジア市場規模・予測 ・女性向け医療の日本市場規模・予測 ・女性向け医療の中国市場規模・予測 ・女性向け医療のインド市場規模・予測 ・女性向け医療の中東市場規模・予測 ・女性向け医療のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Women’s Health Market: Overview
This report on the women’s health market analyzes the current and future scenario of the global market. Rise in number of women facing menopausal condition, rising incidence of women’s diseases, growing awareness among people about the availability of treatment for women’s health related diseases, technological advancements and high R&D investments are major factors driving market growth.
The women’s health market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment type, disease indication, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the women’s health market.
Global Women’s Health Market: Segmentation
Based on treatment type, the market has been segmented into hormonal treatment and non-hormonal treatment. Hormonal treatment segment is subdivided into estrogen therapy, progestin therapy, combination therapy, thyroid replacement therapy, parathyroid hormone therapy, and others. While non-hormonal treatment segment considers cancer targeted therapy drugs, antibiotics, bisphosphonates, and others (vitamin D treatment, calcitonin, RANK-Ligand, non-steroidal anti-inflammatory drugs etc.). The treatment type market segments have been analyzed based on available approved drugs, cost-effectiveness, and prevalence rate by geography. The market size in terms of value (US$) and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on disease indication, the women’s health market has been segmented into following categories: cancer, hypothyroidism, post-menopausal syndrome, osteoporosis, contraceptive, uterine fibroid, urinary tract infection, and other disease indications. The market segments have been extensively analyzed based on new product launches, incidence and prevalence rate, and prescription pattern. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Women’s Health Market: Regional Outlook
Geographically, the global women’s health market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Competitive Landscape
The report also profiles major players in the global women’s health market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players in the women’s health market are – Eli Lilly and Company, Novartis AG, Pfizer, Inc., Merck & Co., Inc., Novo Nordisk A/S, Amgen Inc., Lupin Pharmaceuticals, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Sanofi, Allergan Plc, Bayer AG, GlaxoSmithKline plc, and Johnson & Johnson and others.
The global women’s health market is segmented as given below:
Global Women’s Health Market, by Treatment Type
Hormonal Treatment
Estrogen Therapy
Progestin Therapy
Combination Therapy
Thyroid Replacement Therapy
Parathyroid Hormone Therapy
Others
Non-Hormonal Treatment
Targeted Therapy Drugs
Antibiotics
Bisphosphonates
Others
Global Women’s Health Market, by Disease Indication
Cancer
Breast Cancer
Cervical Cancer
Ovarian Cancer
Hypothyroidism
Post-Menopausal Syndrome
Osteoporosis
Contraceptive
Uterine Fibroid
Urinary Tract Infection
Others
Global Women’s Health Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia and New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of MEA
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Women’s Health Market Snapshot
4. Market Overview
4.1. Market Overview
4.2. Market Opportunity Map
4.3. Key Industry Events
4.4. Global Women’s Health Market Size (US$ Mn) Forecast, 2015–2025
4.5. Global Women’s Health Market Outlook
4.6. Pipeline Analysis
4.7. Key Trends
4.8. Government Initiatives/Key Investments Assessment
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
6. Global Women’s Health Market Analysis, by Treatment Type
6.1. Introduction
6.2. Key Insights
6.3. Global Women’s Health Market Value Share Analysis, by Treatment Type
6.4. Global Women’s Health Market Forecast, by Treatment Type
6.4.1. Hormonal
6.4.1.1. Estrogen
6.4.1.2. Progestin
6.4.1.3. Combination
6.4.1.4. Parathyroid
6.4.1.5. Thyroid
6.4.1.6. Others
6.4.2. Non-Hormonal
6.4.2.1. Targeted Drugs
6.4.2.2. Antibiotics
6.4.2.3. Biphosphonates
6.4.2.4. Others
6.5. Global Women’s Health Market Attractiveness Analysis, by Treatment Type
6.6. Key Trends
7. Global Women’s Health Market Analysis, by Disease Indication
7.1. Introduction
7.2. Key Insights
7.3. Global Women’s Health Market Value Share Analysis, by Treatment Type
7.4. Global Women’s Health Market Forecast, by Treatment Type
7.4.1. Cancer
7.4.1.1. Breast Cancer
7.4.1.2. Cervical Cancer
7.4.1.3. Ovarian Cancer
7.4.2. Hypothyroidism
7.4.3. Menopause
7.4.4. Osteoporosis
7.4.5. Contraceptive
7.4.6. Uterine Fibroid
7.4.7. Urinary Tract Infection
7.5. Global Women’s Health Market Attractiveness Analysis, by Treatment Type
7.6. Key Trends
8. Global Women’s Health Market Analysis, by Region
8.1. Global Women’s Health Market Value Share Analysis, by Region
8.2. Global Women’s Health Market Forecast, by Region, 2015–2025
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
9. North America Women’s Health Market Analysis
9.1. North America Women’s Health Market Overview
9.2. North America Women’s Health Market Value Share Analysis, by Treatment Type
9.3. North America Women’s Health Market Value Share Analysis, by Disease Indication
9.4. North America Women’s Health Market Value Share Analysis, by Country
9.5. North America Women’s Health Market Forecast, by Treatment Type
9.5.1. Hormonal
9.5.1.1. Estrogen
9.5.1.2. Progestin
9.5.1.3. Combination
9.5.1.4. Parathyroid
9.5.1.5. Thyroid
9.5.1.6. Others
9.5.2. Non-Hormonal
9.5.2.1. Targeted Drugs
9.5.2.2. Antibiotics
9.5.2.3. Biphosphonates
9.5.2.4. Others
9.6. North America Women’s Health Market Forecast, by Disease Indication
9.6.1. Cancer
9.6.1.1. Breast Cancer
9.6.1.2. Cervical Cancer
9.6.1.3. Ovarian Cancer
9.6.2. Hypothyroidism
9.6.3. Menopause
9.6.4. Osteoporosis
9.6.5. Contraceptive
9.6.6. Uterine Fibroid
9.6.7. Urinary Tract Infection
9.7. North America Women’s Health Market Forecast, by Country
9.7.1. United States
9.7.2. Canada
9.8. North America Women’s Health Market Attractiveness Analysis,
9.8.1. By Treatment Type
9.8.2. By Disease Indication
9.8.3. By Country
9.9. North America – Key Trends
10. Europe Women’s Health Market Analysis
10.1. Europe Women’s Health Market Overview
10.2. Europe Women’s Health Market Value Share Analysis, by Treatment Type
10.3. Europe Women’s Health Market Value Share Analysis, by Disease Indication
10.4. Europe Women’s Health Market Value Share Analysis, by Country
10.5. Europe Women’s Health Market Forecast, by Treatment Type
10.5.1. Hormonal
10.5.1.1. Estrogen
10.5.1.2. Progestin
10.5.1.3. Combination
10.5.1.4. Parathyroid
10.5.1.5. Thyroid
10.5.1.6. Others
10.5.2. Non-Hormonal
10.5.2.1. Targeted Drugs
10.5.2.2. Antibiotics
10.5.2.3. Biphosphonates
10.5.2.4. Others
10.6. Europe Women’s Health Market Forecast, by Disease Indication
10.6.1. Cancer
10.6.1.1. Breast Cancer
10.6.1.2. Cervical Cancer
10.6.1.3. Ovarian Cancer
10.6.2. Hypothyroidism
10.6.3. Menopause
10.6.4. Osteoporosis
10.6.5. Contraceptive
10.6.6. Uterine Fibroid
10.6.7. Urinary Tract Infection
10.7. Europe Women’s Health Market Forecast, by Country / Sub-region
10.7.1. UK
10.7.2. Germany
10.7.3. France
10.7.4. Italy
10.7.5. Spain
10.7.6. Rest of Europe
10.8. Europe Women’s Health Market Attractiveness Analysis
10.8.1. By Treatment Type
10.8.2. By Disease Indication
10.8.3. By Country / Sub-region
10.9. Europe – Key Trends
11. Asia Pacific Women’s Health Market Analysis
11.1. Asia Pacific Women’s Health Market Overview
11.2. Asia Pacific Women’s Health Market Value Share Analysis, by Treatment Type
11.3. Asia Pacific Women’s Health Market Value Share Analysis, by Disease Indication
11.4. Asia Pacific Women’s Health Market Value Share Analysis, by Country
11.5. Asia Pacific Women’s Health Market Forecast, by Treatment Type
11.5.1. Hormonal
11.5.1.1. Estrogen
11.5.1.2. Progestin
11.5.1.3. Combination
11.5.1.4. Parathyroid
11.5.1.5. Thyroid
11.5.1.6. Others
11.5.2. Non-Hormonal
11.5.2.1. Targeted Drugs
11.5.2.2. Antibiotics
11.5.2.3. Biphosphonates
11.5.2.4. Others
11.6. Asia Pacific Women’s Health Market Forecast, by Disease Indication
11.6.1. Cancer
11.6.1.1. Breast Cancer
11.6.1.2. Cervical Cancer
11.6.1.3. Ovarian Cancer
11.6.2. Hypothyroidism
11.6.3. Menopause
11.6.4. Osteoporosis
11.6.5. Contraceptive
11.6.6. Uterine Fibroid
11.6.7. Urinary Tract Infection
11.7. Asia Pacific Women’s Health Market Forecast, by Country / Sub-region
11.7.1. China
11.7.2. Japan
11.7.3. India
11.7.4. Australia
11.7.5. Rest of APAC
11.8. Asia Pacific Women’s Health Market Attractiveness Analysis
11.8.1. By Treatment Type
11.8.2. By Disease Indication
11.8.3. By Country / Sub-region
11.9. Asia Pacific – Key Trends
12. Latin America Women’s Health Market Analysis
12.1. Latin America Women’s Health Market Overview
12.2. Latin America Women’s Health Market Value Share Analysis, by Treatment Type
12.3. Latin America Women’s Health Market Value Share Analysis, by Disease Indication
12.4. Latin America Women’s Health Market Value Share Analysis, by Country
12.5. Latin America Women’s Health Market Forecast, by Treatment Type
12.5.1. Hormonal
12.5.1.1. Estrogen
12.5.1.2. Progestin
12.5.1.3. Combination
12.5.1.4. Parathyroid
12.5.1.5. Thyroid
12.5.1.6. Others
12.5.2. Non-Hormonal
12.5.2.1. Targeted Drugs
12.5.2.2. Antibiotics
12.5.2.3. Biphosphonates
12.5.2.4. Others
12.6. Latin America Women’s Health Market Forecast, by Disease Indication
12.6.1. Cancer
12.6.1.1. Breast Cancer
12.6.1.2. Cervical Cancer
12.6.1.3. Ovarian Cancer
12.6.2. Hypothyroidism
12.6.3. Menopause
12.6.4. Osteoporosis
12.6.5. Contraceptive
12.6.6. Uterine Fibroid
12.6.7. Urinary Tract Infection
12.7. Latin America Women’s Health Market Forecast, by Country / Sub-region
12.7.1. Brazil
12.7.2. Mexico
12.7.3. Rest of Latin America
12.8. Latin America Women’s Health Market Attractiveness Analysis
12.8.1. By Treatment Type
12.8.2. By Disease Indication
12.8.3. By Country / Sub-region
12.9. Latin America – Key Trends
13. Middle East & Africa Women’s Health Market Analysis
13.1. Middle East & Africa Women’s Health Market Overview
13.2. Middle East & Africa Women’s Health Market Value Share Analysis, by Treatment Type
13.3. Middle East & Africa Women’s Health Market Value Share Analysis, by Disease Indication
13.4. Middle East & Africa Women’s Health Market Value Share Analysis, by Country
13.5. Middle East & Africa Women’s Health Market Forecast, by Treatment Type
13.5.1. Hormonal
13.5.1.1. Estrogen
13.5.1.2. Progestin
13.5.1.3. Combination
13.5.1.4. Parathyroid
13.5.1.5. Thyroid
13.5.1.6. Others
13.5.2. Non-Hormonal
13.5.2.1. Targeted Drugs
13.5.2.2. Antibiotics
13.5.2.3. Biphosphonates
13.5.2.4. Others
13.6. Middle East & Africa Women’s Health Market Forecast, by Disease Indication
13.6.1. Cancer
13.6.1.1. Breast Cancer
13.6.1.2. Cervical Cancer
13.6.1.3. Ovarian Cancer
13.6.2. Hypothyroidism
13.6.3. Menopause
13.6.4. Osteoporosis
13.6.5. Contraceptive
13.6.6. Uterine Fibroid
13.6.7. Urinary Tract Infection
13.7. Middle East & Africa Women’s Health Market Forecast, by Country / Sub-region
13.7.1. GCC Countries
13.7.2. South Africa
13.7.3. Rest of Middle East & Africa
13.8. Middle East & Africa Women’s Health Market Attractiveness Analysis
13.8.1. By Treatment Type
13.8.2. By Disease Indication
13.8.3. By Country / Sub-region
13.9. Middle East & Africa – Key Trends
14. Competition Landscape
14.1. Competitive Positioning
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Eli Lilly and Company
14.3.1.1. Overview (HQ, Employee Strength, Business Segments)
14.3.1.2. Financials
14.3.1.3. Recent Developments
14.3.1.4. Strategy
14.3.2. Novartis AG
14.3.2.1. Overview (HQ, Employee Strength, Business Segments)
14.3.2.2. Financials
14.3.2.3. Recent Developments
14.3.2.4. Strategy
14.3.3. Pfizer, Inc.
14.3.3.1. Overview (HQ, Employee Strength, Business Segments)
14.3.3.2. Financials
14.3.3.3. Recent Developments
14.3.3.4. Strategy
14.3.4. Merck & Co., Inc.
14.3.4.1. Overview (HQ, Employee Strength, Business Segments)
14.3.4.2. Financials
14.3.4.3. Recent Developments
14.3.4.4. Strategy
14.3.5. Novo Nordisk A/S
14.3.5.1. Overview (HQ, Employee Strength, Business Segments)
14.3.5.2. Financials
14.3.5.3. Recent Developments
14.3.5.4. Strategy
14.3.6. Amgen Inc.
14.3.6.1. Overview (HQ, Employee Strength, Business Segments)
14.3.6.2. Financials
14.3.6.3. Recent Developments
14.3.6.4. Strategy
14.3.7. AstraZeneca
14.3.7.1. Overview (HQ, Employee Strength, Business Segments)
14.3.7.2. Financials
14.3.7.3. Recent Developments
14.3.7.4. Strategy
14.3.8. F. Hoffmann-La Roche Ltd.
14.3.8.1. Overview (HQ, Employee Strength, Business Segments)
14.3.8.2. Financials
14.3.8.3. Recent Developments
14.3.8.4. Strategy
14.3.9. Sanofi
14.3.9.1. Overview (HQ, Employee Strength, Business Segments)
14.3.9.2. Financials
14.3.9.3. Recent Developments
14.3.9.4. Strategy
14.3.10. Allergan Plc
14.3.10.1. Overview (HQ, Employee Strength, Business Segments)
14.3.10.2. Financials
14.3.10.3. Recent Developments
14.3.10.4. Strategy
14.3.11. GlaxoSmithKline plc
14.3.11.1. Overview (HQ, Employee Strength, Business Segments)
14.3.11.2. Financials
14.3.11.3. Recent Developments
14.3.11.4. Strategy
14.3.12. Lupin Pharmaceuticals, Inc.
14.3.12.1. Overview (HQ, Employee Strength, Business Segments)
14.3.12.2. Financials
14.3.12.3. Recent Developments
14.3.12.4. Strategy
TABLE 1 Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 2 Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
TABLE 3 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Hormonal Treatment
TABLE 4 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Estrogen Treatment
TABLE 5 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Progestin Treatment
TABLE 6 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Combination Treatment
TABLE 7 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Thyroid Treatment
TABLE 8 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Parathyroid Treatment
TABLE 9 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Others Treatment
TABLE 10 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Non-Hormonal Treatment
TABLE 11 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Targeted Therapy Drugs Treatment
TABLE 12 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Antibiotics Therapy Drugs
TABLE 13 Global Women’s Health Market Revenue (US$ Mn) and Y-o-Y (%) Forecast, by Bisphosphonate Therapy Drugs
TABLE 14 Global Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
TABLE 15 Global Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 16 Global Women’s Health Market Size (US$ Mn) Forecast, by Region, 2015–2025
TABLE 17 North America Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 18 North America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 19 North America Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
TABLE 20 North America Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
TABLE 21 North America Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 22 Europe Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 23 Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 24 Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
TABLE 25 Europe Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
TABLE 26 Europe Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 27 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 28 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 29 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
TABLE 30 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
TABLE 31 Asia Pacific Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 32 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 33 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 34 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Hormonal Treatment, 2015–2025
TABLE 35 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type – Non-Hormonal Treatment, 2015–2025
TABLE 36 Latin America Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025
TABLE 37 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Country, 2015–2025
TABLE 38 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Treatment Type, 2015–2025
TABLE 39 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Hormonal Treatment, 2015–2025
TABLE 40 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Non-hormonal Treatment, 2015–2025
TABLE 41 Middle East & Africa Women’s Health Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025